Diamyd Medical advances AI-powered screening for Type 1 Diabetes within the ASSET Project
Diamyd Medical, in collaboration with Mainly AI and ASSET partners, highlights meaningful progress in AI-driven screening and risk prediction for Type 1 Diabetes at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Amsterdam (March 19–22, 2025). Dr. Gun Forsander (Institute for Clinical Sciences, Sahlgrenska Academy) will present the findings at an invited presentation at the industry symposium sponsored by Sanofi: BRIDGE TO THE FUTURE, Exploring How Innovation Can Evolve the Early Detection and Management of T1D.“Screening of Type 1 Diabetes has become a hot topic